阿尔茨海默病的β淀粉样蛋白假说和tau病理分别解释了什么？
What do the amyloid-beta hypothesis and tau pathology each explain in Alzheimer disease?
淀粉样假说认为淀粉样前体蛋白被异常剪切产生的Aβ42聚集成斑块，触发下游的胶质炎症反应和突触损伤；tau病理则表现为微管相关蛋白tau过度磷酸化、形成神经纤维缠结，其在脑内的扩散范围与认知下降的相关性更紧密。目前主流观点是Aβ沉积在临床前期启动病程，而tau扩散和神经元丢失决定症状进展速度。这也解释了为什么抗Aβ药物更适用于早期患者，而在中晚期获益有限。
The amyloid hypothesis holds that abnormal cleavage of amyloid precursor protein yields amyloid-beta 42, which aggregates into plaques and triggers glial inflammation and synaptic injury; tau pathology involves hyperphosphorylated microtubule-associated tau forming neurofibrillary tangles whose spread correlates more closely with cognitive decline. The prevailing view is that amyloid deposition initiates the disease in the preclinical stage, while tau propagation and neuronal loss set the pace of symptoms. This helps explain why anti-amyloid drugs are aimed at early disease and offer little benefit later on.
难度 专业 · 适合 大众
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：此条未指向带版次的可引用著作（通识性内容、机构文件或未展开的英文书名），本库不提供独立书目出处；如需精确引用，需由编辑补全具体篇目与版次。
The Lancet（阿尔茨海默病综述，2021）
The Lancet (Alzheimer disease seminar, 2021)
#阿尔茨海默病 #淀粉样斑块 #tau蛋白
脑内的类淋巴（glymphatic）通路与睡眠、神经退行有什么关系？
How is the brain glymphatic pathway related to sleep and neurodegeneration?
脑组织没有传统淋巴管，代谢废物主要沿血管周围间隙由脑脊液与组织间液交换带走，这一通路依赖星形胶质细胞足突上的AQP4水通道。动物实验发现睡眠时细胞间隙容积扩大、交换效率明显提高，包括Aβ在内的代谢产物清除增加，提示长期睡眠剥夺可能促进异常蛋白沉积。该机制在人体中的定量证据仍在积累，目前还不能据此推断仅改善睡眠就可以预防神经退行性疾病。
The brain lacks conventional lymphatic vessels, so metabolic waste is largely cleared along perivascular spaces through exchange between cerebrospinal and interstitial fluid, a route that depends on AQP4 water channels on astrocyte end-feet. Animal studies show that during sleep the interstitial space expands and exchange becomes much more efficient, increasing clearance of solutes including amyloid-beta, which suggests chronic sleep deprivation could favour protein accumulation. Quantitative human evidence is still emerging, so it would be premature to claim that improving sleep alone prevents neurodegenerative disease.
难度 专业 · 适合 高中(15-18)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#类淋巴系统 #AQP4 #睡眠与脑清除
长期服用左旋多巴为什么会出现剂末现象和异动症？
Why does long-term levodopa lead to wearing-off and dyskinesia?
随着黑质神经元继续丢失，纹状体储存并缓慢释放多巴胺的缓冲能力下降，血药浓度波动被直接传递到突触，药效维持时间缩短，即剂末现象。反复的脉冲式受体刺激又使纹状体多巴胺受体下游信号通路发生异常可塑性改变，产生过度活动性的不自主运动，即异动症。临床上通过少量多次给药、加用长效制剂或COMT、MAO-B抑制剂来平滑刺激，症状严重且药物调整无效者可考虑脑深部电刺激。
As nigral neurons continue to die, the striatum loses its capacity to store dopamine and release it steadily, so fluctuations in plasma levodopa are transmitted directly to synapses and each dose lasts less time, which is wearing-off. Repeated pulsatile receptor stimulation then drives maladaptive plasticity in downstream striatal signalling pathways, producing the excessive involuntary movements called dyskinesia. Management smooths stimulation using smaller, more frequent doses, extended-release formulations or COMT and MAO-B inhibitors, with deep brain stimulation considered when medication adjustment fails.
难度 专业 · 适合 高中(15-18)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#左旋多巴 #剂末现象 #异动症
生活方式真的能降低痴呆风险吗？
Can lifestyle changes really lower the risk of dementia?
大型证据综述估计，如果在人群层面改善未矫正的听力损失、低教育水平、高血压、吸烟、肥胖、糖尿病、缺乏运动、社交孤立、抑郁、过量饮酒、空气污染、颅脑外伤、视力损害和高低密度脂蛋白胆固醇这些可干预因素，理论上可预防或延迟约45%的痴呆。这是人群归因估计，并不意味着任何个体一定不发病，但控制这些因素同时对心脑血管健康有益。研究表明中年期开始干预的潜在收益更明显。
Large evidence reviews estimate that addressing modifiable factors at the population level, including uncorrected hearing loss, low education, hypertension, smoking, obesity, diabetes, physical inactivity, social isolation, depression, excessive alcohol, air pollution, head injury, visual loss and high LDL cholesterol, could in theory prevent or delay around forty-five percent of dementia. These are population attributable estimates, so no individual is guaranteed protection, but managing the same factors also benefits cardiovascular and cerebrovascular health. Evidence suggests the potential gain is larger when intervention begins in midlife.
难度 进阶 · 适合 大众
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：本题原挂出处与答案内容不符，已撤回；具体书目待补，暂不展示来源。
本题原挂出处与答案内容不符，已撤回；具体书目待补。
Previous citation withdrawn as unsupported for this answer; a specific source is pending.
#痴呆预防 #可干预风险因素 #中年干预
轻度认知障碍（MCI）一定会发展成痴呆吗？
Does mild cognitive impairment always progress to dementia?
MCI指记忆或其他认知领域出现可被客观测量的下降，但日常生活能力基本保留。随访研究显示每年约有一成多的MCI患者进展为痴呆，同时也有相当比例长期保持稳定，甚至在抑郁、睡眠呼吸暂停、甲状腺功能低下、维生素B12缺乏或药物副作用等可逆因素被纠正后恢复。一般建议先系统排查这些可逆病因，并通过控制血压血糖、规律运动和保持认知社交活动来降低进展风险。
Mild cognitive impairment means measurable decline in memory or another cognitive domain while everyday function is largely preserved. Follow-up studies find that somewhat over ten percent of people with MCI progress to dementia each year, yet a substantial share stay stable long term and some improve once reversible contributors such as depression, sleep apnoea, hypothyroidism, vitamin B12 deficiency or medication side effects are corrected. It is generally advised to look systematically for these reversible causes and to reduce risk by controlling blood pressure and glucose, exercising regularly and staying cognitively and socially active.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-08-23 · 2 条独立证据
来源 · Source
Harrison's Principles of Internal Medicine 第20版,McGraw-Hill,2018
J. Loscalzo et al., Harrison's Principles of Internal Medicine, 20th ed., McGraw-Hill, 2018
独立核验依据 · Independent verification: 核验依据 2 OPENLIBRARY ISBN 标识 9781259644047（按标识回读: Harrison's prin
#轻度认知障碍 #可逆病因 #痴呆风险
帕金森病患者为什么会手抖、动作变慢？
Why do people with Parkinson disease develop tremor and slowed movement?
中脑黑质致密部的多巴胺神经元大量退化，导致纹状体多巴胺不足，基底核-皮质环路对运动的启动和抑制失衡，表现为静止性震颤、肌张力增高、动作迟缓和姿势步态障碍。通常在多巴胺神经元丢失过半后才出现明显运动症状，因此确诊时病理过程往往已持续多年。嗅觉减退、便秘和睡眠中大声喊叫、拳打脚踢等非运动症状常在运动症状之前出现。
Dopaminergic neurons in the substantia nigra pars compacta degenerate, so striatal dopamine falls and the basal ganglia-cortical loops lose balance between initiating and suppressing movement, producing rest tremor, rigidity, bradykinesia and postural or gait problems. Obvious motor signs usually appear only after more than half of these neurons are lost, so the underlying process has often run for years before diagnosis. Non-motor features such as reduced smell, constipation and shouting or thrashing during sleep frequently precede the motor symptoms.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：此条未指向带版次的可引用著作（通识性内容、机构文件或未展开的英文书名），本库不提供独立书目出处；如需精确引用，需由编辑补全具体篇目与版次。
The Lancet（帕金森病综述，2021）
The Lancet (Parkinson disease seminar, 2021)
#帕金森病 #多巴胺神经元 #基底核
血脑屏障是什么？为什么它让脑部疾病的用药特别困难？
What is the blood-brain barrier and why does it make treating brain disease so hard?
血脑屏障由脑毛细血管内皮细胞之间的紧密连接、基膜和星形胶质细胞足突共同构成，能阻挡大分子和多数亲水物质进入脑组织，同时借转运体主动排出外来物质，从而维持中枢神经系统稳定的内环境。药物通常需要分子量小、脂溶性高或借助特定载体才能通过，因此许多在体外有效的大分子药物到不了病灶。研究者正尝试聚焦超声短暂开窗、受体介导转运和鼻腔给药等递送策略。
The blood-brain barrier is formed by tight junctions between brain capillary endothelial cells, the basement membrane and astrocyte end-feet; it blocks large molecules and most hydrophilic substances while efflux transporters actively pump foreign compounds out, keeping the central nervous system environment stable. Drugs generally need low molecular weight, high lipid solubility or a specific carrier to cross, so many large molecules that work in the laboratory never reach their target. Researchers are testing delivery strategies such as focused-ultrasound opening, receptor-mediated transport and intranasal administration.
难度 进阶 · 适合 初中(12-15)
CC BY 4.0 · 已核验 · Verified 2026-10-03
来源 · Source
《生理学》（血脑屏障与中枢神经系统内环境）
Physiology (blood-brain barrier and the CNS internal environment)
#血脑屏障 #药物递送 #中枢神经系统
抗淀粉样蛋白单抗真的能治好阿尔茨海默病吗？
Do anti-amyloid antibodies actually cure Alzheimer disease?
三期试验显示，这类单抗能显著清除脑内淀粉样斑块，并使早期患者在18个月内的认知与功能量表下降速度减慢约四分之一，属于延缓进展而不是逆转或治愈。用药前需通过PET或脑脊液确认淀粉样病理阳性，治疗期间要用MRI监测淀粉样相关影像异常，即脑水肿和微出血。一般建议在具备生物标志物检测与影像随访条件的机构评估后使用，并充分权衡获益与风险。
Phase 3 trials show these antibodies markedly clear amyloid plaques and slow decline on cognitive and functional scales by roughly a quarter over 18 months in early disease, which means slowing progression rather than reversal or cure. Amyloid pathology must be confirmed by PET or cerebrospinal fluid testing before treatment, and MRI monitoring is needed for amyloid-related imaging abnormalities, that is brain oedema and microhaemorrhage. It is generally recommended that such therapy be started only in centres able to perform biomarker testing and imaging follow-up, after weighing benefits against risks.
难度 进阶 · 适合 大众
CC BY 4.0 · 来源待核验 · Source pending review
来源 · Source
出处备注：著录含书名，但缺版次 / 出版社 / 年份中的一部分，需编辑补全后才能做独立比对。
《新英格兰医学杂志》(NEJM)（van Dyck 等，Clarity AD 仑卡奈单抗三期试验，2023）
NEJM (van Dyck et al., Clarity AD phase 3 trial of lecanemab, 2023)
#抗淀粉样单抗 #ARIA #疾病修饰治疗